Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 08, 2025 07:09 ET | Source: Nilo Therapeutics

Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer

Nilo Therapeutics launches with $101 million Series A to target neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer
June 09, 2022 07:00 ET | Source: Web3 Ventures

Web3 Ventures Completes Strategic Investment in Decentralized Social Media Network, Column

TORONTO, June 09, 2022 (GLOBE NEWSWIRE) -- Web3 Ventures Inc. (“W3V” or the “Company”), a platform company focused on incubating, accelerating, and developing world class projects and applications...